Inventor · disambiguated record
Henning Thoegersen
Also filed as: THOEGERSEN HENNING
22 granted patents·21 pending applications·99 citations·filing 2011–2024
95Inventor score
Top patents by PatentIndex Score
43 records- 0192US9272019B2MIC-1 fusion proteins and uses thereofNOVO NORDISK AS·Filed 2015·Granted Mar 1, 2016·11 cites·29 claims
- 0291US9067977B2Peptides derivatized with A-B-C-D- and their therapeutical useNOVO NORDISK AS·Filed 2013·Granted Jun 30, 2015·18 cites·22 claims
- 0391US8575090B2Amylin analogues and pharmaceutical compositions thereofSCHAEFFER LAUGE·Filed 2012·Granted Nov 5, 2013·16 cites·11 claims
- 0488US10398782B2MIC-1 compounds and uses thereofNOVO NORDISK AS·Filed 2018·Granted Sep 3, 2019·5 cites·28 claims
- 0587US11767332B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2021·Granted Sep 26, 2023·1 cites·3 claims
- 0686US11186595B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2018·Granted Nov 30, 2021·3 cites·13 claims
- 0785US8741836B2PolypeptidesSCHAEFFER LAUGE·Filed 2012·Granted Jun 3, 2014·7 cites·12 claims
- 0884US10604555B2GIP derivatives and uses thereofNOVO NORDISK AS·Filed 2019·Granted Mar 31, 2020·5 cites·30 claims
- 0984US9409966B2Glucagon-like peptide-1 derivatives and their pharmaceutical useNOVO NORDISK AS·Filed 2014·Granted Aug 9, 2016·6 cites·22 claims
- 1084US8722849B2PolypeptidesSCHAEFFER LAUGE·Filed 2012·Granted May 13, 2014·6 cites·19 claims
- 1184US8541368B2Glucagon analoguesNOVO NORDISK AS·Filed 2012·Granted Sep 24, 2013·6 cites·41 claims
- 1282US9956264B2MIC-1 fusion proteins and uses thereofNOVO NORDISK AS·Filed 2016·Granted May 1, 2018·4 cites·10 claims
- 1381US12227528B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2023·Granted Feb 18, 2025·0 cites·4 claims
- 1481US2025122226A1Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 1580US11633459B2GIP derivatives and uses thereofNOVO NORDISK AS·Filed 2019·Granted Apr 25, 2023·1 cites·19 claims
- 1679US12006344B2MIC-1 compounds and use thereofNOVO NORDISK AS·Filed 2022·Granted Jun 11, 2024·0 cites·1 claims
- 1777US9029325B2Amylin analogues and pharmaceutical compositions thereofNOVO NORDISK AS·Filed 2013·Granted May 12, 2015·2 cites·11 claims
- 1876US9486505B2Glucagon analoguesNOVO NORDISK AS·Filed 2013·Granted Nov 8, 2016·2 cites·23 claims
- 1974US10822385B2EGF(A) analogues with fatty acid substituentsNOVO NORDISK AS·Filed 2017·Granted Nov 3, 2020·1 cites·28 claims
- 2073US2024190938A1Gip derivatives and uses thereofNOVO NORDISK AS·Filed 2023·Application pending·0 cites
- 2171US9486506B2Glucagon analoguesNOVO NORDISK AS·Filed 2015·Granted Nov 8, 2016·1 cites·17 claims
- 2268US9988430B2Stable GLP-1 based GLP-1/glucagon receptor co-agonistsNOVO NORDISK AS·Filed 2015·Granted Jun 5, 2018·1 cites·29 claims
- 2368US2023364248A1Mic-1 compounds and uses thereofNOVO NORDISK AS·Filed 2022·Application pending·0 cites
- 2465US9040660B2Long-acting gastrin derivativesKOFOED JACOB·Filed 2011·Granted May 26, 2015·2 cites·3 claims
- 2565US2021198331A1Mic-1 compounds and use thereofNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 2664US2018016319A1Acylated Glucagon AnaloguesNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 2762US2017190757A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 2861US2016271263A1Acylated Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 2960US2017051034A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 3058US2015274801A1Acylated glucagon analoguesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 3157US9655974B2N-terminal modified FGF21 compoundsTAGMOSE TINA MOELLER·Filed 2011·Granted May 23, 2017·1 cites·4 claims
- 3257US2013035285A1Novel glucagon analoguesNOVO NORDISK AS·Filed 2011·Application pending·0 cites
- 3357US2016002311A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 3457US2020407409A1Egf(a) analogues with fatty acid substituentsCHEN JIANHE·Filed 2020·Application pending·0 cites
- 3557US2013143798A1Novel glucagon analoguesLAU JESPER F·Filed 2011·Application pending·0 cites
- 3654US2016347812A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 3750US2019248852A1MIC-1 Compounds and Use ThereofNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 3844US2022184184A1Glucose sensitive insulin derivativesNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 3942US2014031278A1Novel Glucagon AnaloguesLAU JESPER F·Filed 2012·Application pending·0 cites
- 4040US2015344540A1Novel glp-1 receptor agonists with cholesterol efflux activityNOVO NORDISK AS·Filed 2013·Application pending·0 cites
- 4140US2013252884A1Fgf21 analogues and derivativesGARIBAY PATRICK WILLIAM·Filed 2011·Application pending·0 cites
- 4238US2015368313A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 4335US2013012432A1Peptides for Treatment of ObesityNOVO NORDISK AS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henning Thoegersen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →